DENVER — In this Healio Video Perspective from the ARVO meeting, Jason S. Slakter, MD, discusses his poster on phase 2b study results of OPT-302 (Opthea) in combination with ranibizumab for wet age-related macular degeneration.
VIDEO: OPT-302 with ranibizumab improved vision in patients with wet AMD
DENVER — In this Healio Video Perspective from the ARVO meeting, Jason S. Slakter, MD, discusses his poster on phase 2b study results of OPT-302 (Opthea) in combination with ranibizumab for wet age-related macular degeneration.